Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer (Q33931167)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

30 July 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

Daniele Santini

12

object named as

Daniele Santini

1 reference

Europe PubMed Central

30 July 2017

Marta Schirripa

object named as

Marta Schirripa

7

1 reference

ORCID Public Data File 2021

Chiara Cremolini

object named as

Chiara Cremolini

4

1 reference

ORCID Public Data File 2021

Nadia Galluccio

object named as

Nadia Galluccio

9

1 reference

ORCID Public Data File 2021

18

object named as

Mauro Magnani

1 reference

Europe PubMed Central

30 July 2017

11

object named as

Bruno Vincenzi

1 reference

Europe PubMed Central

30 July 2017

Giuseppe Tonini

17

object named as

Giuseppe Tonini

1 reference

Europe PubMed Central

30 July 2017

5

object named as

Gianluca Masi

1 reference

Europe PubMed Central

30 July 2017

Alfredo Falcone

19

object named as

Alfredo Falcone

1 reference

Europe PubMed Central

30 July 2017

Fotios Loupakis

1

object named as

Fotios Loupakis

1 reference

Europe PubMed Central

30 July 2017

Annamaria Ruzzo

2

object named as

Annamaria Ruzzo

1 reference

Europe PubMed Central

30 July 2017

Vincenzo Catalano

8

object named as

Vincenzo Catalano

1 reference

Europe PubMed Central

30 July 2017

Emanuele Canestrari

10

object named as

Emanuele Canestrari

1 reference

Europe PubMed Central

30 July 2017

author name string

Lisa Salvatore

3

1 reference

Europe PubMed Central

30 July 2017

Paolo Frumento

6

1 reference

Europe PubMed Central

30 July 2017

Katia Bencardino

13

1 reference

Europe PubMed Central

30 July 2017

Vincenzo Ricci

14

1 reference

Europe PubMed Central

30 July 2017

Mariangela Manzoni

15

1 reference

Europe PubMed Central

30 July 2017

Marco Danova

16

1 reference

Europe PubMed Central

30 July 2017

Francesco Graziano

20

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

14 June 2011

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

247

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-247

0 references

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Treatment in advanced colorectal cancer: what, when and how?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

5 July 2018

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-247

21 January 2018

Race to report: are vascular endothelial growth factor genetic polymorphisms associated with outcome in advanced breast cancer patients treated with Paclitaxel plus bevacizumab?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125285

29 October 2018

Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21669012

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production

1 reference

https://pubmed.ncbi.nlm.nih.gov/21669012

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-247

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33931167&oldid=1858813057"